Anticipating India's leadership role in BRICS starting 2026, World Health Innovation Forum’s (WHIF) invitation to the BRICS+ Manufacturing Working Group was afforded because of Andhra Pradesh MedTech Zone’s (AMTZ) thought leadership in developing...
Eisai Pharma, a global leader in human healthcare innovation, has announced plans to establish a state-of-the-art Global Capability Centre (GCC) in Visakhapatnam, Andhra Pradesh.
.jpeg "MTaI Flags MMC Move Letting Homoeopaths Use Modern Medicines")
The Medical Technology Association of India (MTaI) has strong objections to a recent notification issued by the Maharashtra Medical Council (MMC) that allows homoeopathy practitioners to administer allopathic drugs
India's pharmaceutical sector is undergoing a significant transformation, both in the discovery of new medicines and advancements in drug delivery.
President Donald Trump on Tuesday announced a possible 200% tariff on imported pharmaceuticals. Speaking at a White House cabinet meeting, he said the goal is to push drug companies to make their medicines in the U.S. instead of overse...
In a significant flashpoint for the medical community, allopathic doctors in Maharashtra have threatened to go on strike on July 11 over the state's plan to allow homeopathic practitioners to register with the Maharashtra Medical Council (MMC) by...
The 4th Edition Drug Safety Symposium 2025 – India Chapter, hosted by Eminence Business Media, once again proved to be a cornerstone event in the evolving landscape of pharmacovigilance in India. With the theme “Beyond Compliance – Creating a Future
Sun Pharmaceutical Industries is working toward a complete regulatory resolution for three of its manufacturing facilities that are being reviewed by the US Food and Drug Administration (USFDA). Sun Pharmaceutical has completed way of corrective...
At the CII Telangana, "Pillars of Protection" conference on pharmaceutical manufacturing safety in Hyderabad, government officials and industry professionals highlighted that safety needs to be embedded in every aspect of their operations...
VarmX, a Dutch-based biotech company headquartered in Leiden, has been given clearance by the U. S. FDA to carry out a pivotal Phase 3 clinical trial on its lead candidate, the VMX-C001. The novel bypass agent can be used to reactivate coagulati...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")